Reports Q2 revenue $8.7M vs. $7.9M a year ago. "Our second quarter results reflect the ongoing strength of our business, including the adoption of our Platform by new customers and the second consecutive quarter of revenue growth in our Transactions business," said Roy W. Olivier, President and CEO of Research Solutions. "The increase in ARR during the quarter reflects the onboarding of new customers, expanded use of the Platform by existing customers including upgrades, and our new Curedatis offering introduced during the quarter. We believe our products deliver a solid return on investment to our customers and we continue to maintain good retention and positive upsell momentum in the present economic environment. While onboarding new customers has proved more challenging in recent quarters, I remain confident in the long-term growth prospects of our Platforms offering and our ability to attract and retain new customers."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on RSSS:
